SCHEMBL6438465

SCHEMBL6438465

NC(=S)N/N=C/c1cc(N2CCN(Cc3cccc(Cl)c3)CC2)ccc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
ALOX12 P18054 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
HCRTR1 O43613 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPT P10636 5/20 0.45
TSHR P16473 1/20 0.45
KDM4E B2RXH2 3/20 0.42
SIGMAR1 Q99720 1/20 0.41
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
HTR1A P08908 1/20 0.39
HTR7 P34969 1/20 0.39
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TP53 P04637 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4455861 1.00 ALDH1A1 (0.46) ALDH1A1ALOX12NPSR1HCRTR1CYP1A2
SCHEMBL4330730 0.93 ALDH1A1 (0.46) ALDH1A1ALOX12NPSR1HCRTR1CYP1A2
SCHEMBL4330727 0.93 ALDH1A1 (0.46) ALDH1A1ALOX12NPSR1HCRTR1CYP1A2
SCHEMBL4329336 0.86 ALDH1A1 (0.49) ALDH1A1ALOX12NPSR1HCRTR1CYP1A2
SCHEMBL4329338 0.86 ALDH1A1 (0.49) ALDH1A1ALOX12NPSR1HCRTR1CYP1A2
SCHEMBL4334397 0.83 CA1 (0.53) ALDH1A1ALOX12NPSR1HCRTR1CYP1A2
SCHEMBL4334400 0.83 CA1 (0.53) ALDH1A1ALOX12NPSR1HCRTR1CYP1A2
SCHEMBL4338895 0.82 PKM (0.44) ALDH1A1ALOX12NPSR1HCRTR1CYP1A2
SCHEMBL4338897 0.82 PKM (0.44) ALDH1A1ALOX12NPSR1HCRTR1CYP1A2
SCHEMBL4329352 0.82 MAPK1 (0.44) ALDH1A1KDM4EMAPK1HTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050069555-A1 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050069555-A1 Thiosemicarbazones as anti-virals and immunopotentiators MAVS, IRF3, HAVCR2 ALDH1A1 1173/4885ALOX12 952/4885NPSR1 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.